{
    "organizations": [],
    "uuid": "86e4a002d239effdaa9bd282edcbf1015ff2e866",
    "author": "",
    "url": "https://www.reuters.com/article/brief-mercks-keytruda-approved-in-japan/brief-mercks-keytruda-approved-in-japan-for-use-in-the-treatment-of-patients-with-urothelial-carcinoma-idUSFWN1OX05F",
    "ord_in_thread": 0,
    "title": "BRIEF-Merck’s Keytruda Approved In Japan For Use In The Treatment Of Patients With Urothelial Carcinoma",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 09 PM / in 12 minutes BRIEF-Merck’s Keytruda Approved In Japan For Use In The Treatment Of Patients With Urothelial Carcinoma Reuters Staff 1 Min Read \nJan 2 (Reuters) - Merck & Co Inc: \n* MERCK’S KEYTRUDA® (PEMBROLIZUMAB) APPROVED IN JAPAN FOR USE IN THE TREATMENT OF PATIENTS WITH UROTHELIAL CARCINOMA THAT IS UNRESECTABLE WITH RADICAL SURGERY WHO HAVE PROGRESSED FOLLOWING CANCER CHEMOTHERAPY \n* MERCK & CO INC - WILL MARKET KEYTRUDA IN JAPAN AND WILL PROMOTE IT WITH TAIHO PHARMACEUTICAL CO LTD \n* MERCK & CO INC - WITH THE APPROVAL, KEYTRUDA IS NOW INDICATED FOR USE IN FOUR TYPES OF CANCER IN JAPAN  ",
    "published": "2018-01-02T14:09:00.000+02:00",
    "crawled": "2018-01-02T14:23:12.010+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "minute",
        "keytruda",
        "approved",
        "japan",
        "use",
        "treatment",
        "patient",
        "urothelial",
        "carcinoma",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "merck",
        "co",
        "inc",
        "merck",
        "pembrolizumab",
        "approved",
        "japan",
        "use",
        "treatment",
        "patient",
        "urothelial",
        "carcinoma",
        "unresectable",
        "radical",
        "surgery",
        "progressed",
        "following",
        "cancer",
        "chemotherapy",
        "merck",
        "co",
        "inc",
        "market",
        "keytruda",
        "japan",
        "promote",
        "taiho",
        "pharmaceutical",
        "co",
        "ltd",
        "merck",
        "co",
        "inc",
        "approval",
        "keytruda",
        "indicated",
        "use",
        "four",
        "type",
        "cancer",
        "japan"
    ]
}